KHPG(SZ:002773)2022-12-04 06:58Group 1: Company Overview - Chengdu Kanghong Pharmaceutical Group Co., Ltd. is focused on innovative drug research and development, particularly in the central nervous system field [2][4]. - The company has a commitment to long-term goals and sustainable operations, with significant investments in R&D [4]. Group 2: R&D Strategy - The company aims to establish an efficient R&D team and continuously seek specialized talent in relevant fields [5]. - Kanghong's research areas include ophthalmology, central nervous system disorders, and oncology, with a focus on diseases lacking satisfactory treatment options, including rare diseases [6]. Group 3: Project Management and Success Rates - The company employs a balanced project strategy, including First in Class, Best in Class, and Fast Follower projects, to enhance the success rate of R&D [6]. - Kanghong emphasizes the importance of translational medicine, especially for multi-target drugs, to improve clinical research speed and success rates [7]. Group 4: Team and Collaboration - The company has established a collaborative environment with domestic and international research institutions to explore new targets and innovative treatment pathways [6]. - Kanghong's project management is structured to facilitate efficient progress, with independent project management teams formed at the candidate compound stage [7].